Translational Immunology and Infectious Diseases Institute (TIIDI)
Led by Founding Director Dr. David Topham, Ph.D., the mission of this Institute is to:
- Conduct clinical and translational research to understand the etiology and impact of viral, bacterial, and fungal pathogens, the immune responses to them, and to develop and evaluate knowledge-based strategies for their control, treatment, and prevention. Multidisciplinary, team-science approaches to critical issues in infectious diseases are essential to this mission.
- Education and training of clinician scientists in adult and pediatric infectious disease and immunology. Committed to the support of developing the careers of young investigators interested in pursuing research.
About the Program
To conduct clinical and translational research to understand the etiology and impact of viral, bacterial, and fungal pathogens, the immune responses to them, and to develop and evaluate knowledge-based strategies for their control, treatment, and prevention.
Leadership
Led by Dr. David Topham, PhD (Founding Director) and Angela Branche, MD (Director of Clinical Studies of Infectious Disease).
Our Faculty
Composed of multidisciplinary scientists with research interests in immunology, microbiology, virology, bioinformatics, and computational
biology.
Latest News
December 2, 2024
URMC conducts research on possible COVID-19 nasal booster
June 20, 2024
What Is H5N1 Bird Flu, How it Spreads to Humans, and Safety Concerns
February 23, 2023
UR TIIDI Pilot Program Call for Applications
October 5, 2022
MSTP awarded research grant
July 15, 2022
NIH-NIMH Grant Funds Research on the Microbiome and Infant Neurodevelopment
Announcements
UR TIIDI Pilot Awardees have been selected!
Visit the awards page to see the awardees.